Subclinical liver traits are associated with structural and hemodynamic brain imaging markers

Impaired liver function affects brain health and therefore understanding potential mechanisms for subclinical liver disease is essential. We assessed the liver–brain associations using liver measures with brain imaging markers, and cognitive measures in the general population.

[1]  Jiajia Zhu,et al.  Associations of Serum Liver Function Markers With Brain Structure, Function, and Perfusion in Healthy Young Adults , 2021, Frontiers in Neurology.

[2]  J. Hendrikse,et al.  Reduced parenchymal cerebral blood flow is associated with greater progression of brain atrophy: The SMART-MR study , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Brenda C T Kieboom,et al.  Objectives, design and main findings until 2020 from the Rotterdam Study , 2020, European Journal of Epidemiology.

[4]  Han-Yeong Jeong,et al.  Favorable impact of non‐alcoholic fatty liver disease on the cerebral white matter hyperintensity in a neurologically healthy population , 2019, European journal of neurology.

[5]  H. Kwon,et al.  Abdominal fatness and cerebral white matter hyperintensity , 2019, Journal of the Neurological Sciences.

[6]  A. Beiser,et al.  NON-ALCOHOLIC FATTY LIVER DISEASE, LIVER FIBROSIS SCORE AND COGNITIVE FUNCTION IN MIDDLE-AGED ADULTS: THE FRAMINGHAM STUDY , 2019, Alzheimer's & Dementia.

[7]  Xianlin Han,et al.  Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers , 2019, JAMA network open.

[8]  Han-Yeong Jeong,et al.  High triglyceride/HDL cholesterol ratio is associated with silent brain infarcts in a healthy population , 2019, BMC Neurology.

[9]  E. Guallar,et al.  Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals , 2019, Scientific Reports.

[10]  Han-Yeong Jeong,et al.  Serum gamma-glutamyl transferase is associated with silent brain infarcts in a healthy population. , 2019, Atherosclerosis.

[11]  J. Lazarus,et al.  Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. , 2018, Journal of hepatology.

[12]  Donghee Kim,et al.  Non‐obese fatty liver disease is associated with lacunar infarct , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[13]  M. A. Khan,et al.  Clinical epidemiology and disease burden of nonalcoholic fatty liver disease , 2017, World journal of gastroenterology.

[14]  B. Johansson,et al.  Gamma-Glutamyltransferase (GGT) as a biomarker of cognitive decline at the end of life: contrasting age and time to death trajectories , 2017, International Psychogeriatrics.

[15]  Axel Montagne,et al.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease , 2017, Nature Reviews Neuroscience.

[16]  C. Lewis,et al.  Nonalcoholic Fatty Liver Disease and Measures of Early Brain Health in Middle Aged Adults: The CARDIA study , 2016, Obesity.

[17]  J. Laukkanen,et al.  Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study , 2016, Alzheimer's & Dementia.

[18]  Boris Gutman,et al.  Bi-directional changes in fractional anisotropy after experiment TBI: Disorganization and reorganization? , 2016, NeuroImage.

[19]  G. Marchesini,et al.  The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease , 2016, Medicine.

[20]  Jeanne M. Clark,et al.  Nonalcoholic fatty liver disease is associated with cognitive function in adults , 2016, Neurology.

[21]  A. Hofman,et al.  The Rotterdam Scan Study: design update 2016 and main findings , 2015, European Journal of Epidemiology.

[22]  S. Seneff,et al.  Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk , 2015, Disease markers.

[23]  S. Rajesh,et al.  Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis. , 2015, Current problems in diagnostic radiology.

[24]  Koenraad Van Leemput,et al.  A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI , 2015, NeuroImage.

[25]  Aad van der Lugt,et al.  Patterns of cognitive function in aging: the Rotterdam Study , 2014, European Journal of Epidemiology.

[26]  V. de Lédinghen,et al.  Determination of reliability criteria for liver stiffness evaluation by transient elastography , 2013, Hepatology.

[27]  R. Lipton,et al.  Robust detection of traumatic axonal injury in individual mild traumatic brain injury patients: Intersubject variation, change over time and bidirectional changes in anisotropy , 2012, Brain Imaging and Behavior.

[28]  S. Czernichow,et al.  Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years , 2010, Gut.

[29]  R. Prakash,et al.  Mechanisms, diagnosis and management of hepatic encephalopathy , 2010, Nature Reviews Gastroenterology &Hepatology.

[30]  Wiro J. Niessen,et al.  Accuracy and reproducibility study of automatic MRI brain tissue segmentation methods , 2010, NeuroImage.

[31]  A. McCullough,et al.  Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. , 2009, Journal of hepatology.

[32]  Stefan Klein,et al.  Iterative Co-linearity Filtering and Parameterization of Fiber Tracts in the Entire Cingulum , 2009, MICCAI.

[33]  A. Toga,et al.  Brain Structure and Obesity , 2009, NeuroImage.

[34]  Wiro J Niessen,et al.  White matter microstructural integrity and cognitive function in a general elderly population. , 2009, Archives of general psychiatry.

[35]  Y. Yılmaz,et al.  Liver disease as a risk factor for cognitive decline and dementia: An Under‐recognized issue , 2009, Hepatology.

[36]  Sarah Aldred,et al.  Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. , 2008, Journal of Alzheimer's disease : JAD.

[37]  K. Aytemir,et al.  Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's disease , 2008, International Psychogeriatrics.

[38]  Aad van der Lugt,et al.  Total Cerebral Blood Flow and Total Brain Perfusion in the General Population: The Rotterdam Scan Study , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  Ronald A. Cohen,et al.  Relationship Between Body Mass Index and Brain Volume in Healthy Adults , 2008, The International journal of neuroscience.

[40]  Yuichi Harano,et al.  The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Reflects the Metabolic Syndrome and Visceral Fat Accumulation , 2007, The American Journal of Gastroenterology.

[41]  A. Yamashina,et al.  Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. , 2006, Atherosclerosis.

[42]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[43]  F. Larsen,et al.  Liver function, cerebral blood flow autoregulation, and hepatic encephalopathy in fulminant hepatic failure , 1997, Hepatology.

[44]  R. Vasan,et al.  Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study , 2018, JAMA neurology.

[45]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .